Anastrozole and Clascoterone Interaction

Monitor
Mechanism-based 60% confidence

Anastrozole and Clascoterone have an interaction requiring monitoring for interaction with 60% confidence. Both Anastrozole and Clascoterone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. These compounds primarily affect different organ systems.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Clascoterone

Topical Androgen Receptor Inhibitor | Acne & Hair Loss

Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).

Half-life: Short topical (local action; rapidly metabolized to cortexolone) Typical dose: Acne: 1% cream 2x/day | Hair loss: 7.5% solution once daily hair loss, skin
androgen receptorngf androgenicteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low
Skin
low

Shared Safety Flags

2x 2 androgenic compounds (Anastrozole, Clascoterone). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the teratogenic safety flag (Anastrozole, Clascoterone). Monitor accordingly.

Frequently Asked Questions

Can I take Anastrozole with Clascoterone?

Yes, but with caution. Both Anastrozole and Clascoterone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.

Is Anastrozole and Clascoterone safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic, teratogenic. Monitor accordingly.

What are the interactions between Anastrozole and Clascoterone?

Both Anastrozole and Clascoterone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anastrozole and Clascoterone?

Anastrozole has a half-life of ~40-50 hours and Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anastrozole vs Clascoterone

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.